Last 12 months
Inside the activity.
14 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 11 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Pisano WayneDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027095 · ownership.xml · derivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
RIGBY JONATHANDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027097 · ownership.xml · derivative · entry 1 RIGBY JONATHAN · CIK 0001356227 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Holtham AngelaDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027092 · ownership.xml · derivative · entry 1 Holtham Angela · CIK 0002102488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Parsons James T.Director
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027089 · ownership.xml · derivative · entry 1 Parsons James T. · CIK 0001759855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Look KirkChief Financial Officer
|
GrantStock Option · Derivative | 260,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027091 · ownership.xml · derivative · entry 1 Look Kirk · CIK 0002103582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Shares · 260,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Aromando AndrewChief Business Officer
|
GrantStock Option · Derivative | 260,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027088 · ownership.xml · derivative · entry 1 Aromando Andrew · CIK 0001976455 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Shares · 260,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Kelly JaredDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 755,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027084 · ownership.xml · derivative · entry 1 Kelly Jared · CIK 0002103581 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 755,000 Underlying: Common Shares · 755,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Andrews Patricia SDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027083 · ownership.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Seizinger Bernd R.Director
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027081 · ownership.xml · derivative · entry 1 Seizinger Bernd R. · CIK 0001789042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Hagerman AllisonChief Technology Officer
|
GrantStock Option · Derivative | 260,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027080 · ownership.xml · derivative · entry 1 Hagerman Allison · CIK 0002103583 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Shares · 260,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Brown Deborah MargaretDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027099 · ownership.xml · derivative · entry 1 Brown Deborah Margaret · CIK 0002103580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Heineman Thomas CharlesChief Medical Officer
|
GrantStock Option · Derivative | 260,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027078 · ownership.xml · derivative · entry 1 Heineman Thomas Charles · CIK 0002103579 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Shares · 260,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
McAdory John BeardenChief Operating Officer
|
GrantStock Option · Derivative | 145,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027101 · ownership.xml · derivative · entry 1 McAdory John Bearden · CIK 0002137500 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Shares · 145,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC |
Glover Stephen C.Director
|
GrantStock Option · Derivative | 96,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001493152-26-027100 · ownership.xml · derivative · entry 1 Glover Stephen C. · CIK 0001304406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Shares · 96,000 shares Expires 2036-06-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026. F2 · derivative.exercise_date: The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 12:00 UTC |
Kelly JaredDirector · Chief Executive Officer
|
PurchaseCommon Shares | 5,050 | $0.96 | $4,848.00 |
DisclosureSEC source: 0001493152-26-009982 · ownership.xml · nonDerivative · entry 1 Kelly Jared · CIK 0002103581 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,050 Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 12:00 UTC |
Parsons James T.Director
|
PurchaseCommon Shares | 10,000 | $1.03 | $10,300.00 |
DisclosureSEC source: 0001493152-26-009983 · ownership.xml · nonDerivative · entry 1 Parsons James T. · CIK 0001759855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,849 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Kelly JaredDirector · Chief Executive Officer
|
PurchaseCommon Shares | 29,500 | $0.84 | $24,839.00 |
DisclosureSEC source: 0001493152-26-006545 · ownership.xml · nonDerivative · entry 2 Kelly Jared · CIK 0002103581 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.820 to $0.856, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Look KirkChief Financial Officer
|
PurchaseCommon Shares | 12,000 | $0.84 | $10,104.00 |
DisclosureSEC source: 0001493152-26-006546 · ownership.xml · nonDerivative · entry 1 Look Kirk · CIK 0002103582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,515 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Pisano WayneDirector
|
PurchaseCommon Shares | 30,000 | $0.84 | $25,338.00 |
DisclosureSEC source: 0001493152-26-006547 · ownership.xml · nonDerivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,414 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Heineman Thomas CharlesChief Medical Officer
|
PurchaseCommon Shares | 12,132 | $0.83 | $10,033.16 |
DisclosureSEC source: 0001493152-26-006544 · ownership.xml · nonDerivative · entry 1 Heineman Thomas Charles · CIK 0002103579 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,818 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Brown Deborah MargaretDirector
|
PurchaseCommon Shares | 25,000 | $0.85 | $21,240.00 |
DisclosureSEC source: 0001493152-26-006542 · ownership.xml · nonDerivative · entry 1 Brown Deborah Margaret · CIK 0002103580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,851 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.835 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Hagerman AllisonVP, Product Development
|
PurchaseCommon Shares | 10,000 | $0.83 | $8,298.00 |
DisclosureSEC source: 0001493152-26-006543 · ownership.xml · nonDerivative · entry 1 Hagerman Allison · CIK 0002103583 · VP, Product Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,059 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Seizinger Bernd R.Director
|
PurchaseCommon Shares | 40,000 | $0.85 | $33,864.00 |
DisclosureSEC source: 0001493152-26-006548 · ownership.xml · nonDerivative · entry 2 Seizinger Bernd R. · CIK 0001789042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,991 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 12:00 UTC |
Andrews Patricia SDirector
|
PurchaseCommon Shares | 35,400 | $0.86 | $30,291.78 |
DisclosureSEC source: 0001493152-26-006540 · ownership.xml · nonDerivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,128 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8483 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 12:00 UTC |
Kelly JaredDirector · Chief Executive Officer
|
PurchaseCommon Shares | 5,600 | $0.84 | $4,681.60 |
DisclosureSEC source: 0001493152-26-006545 · ownership.xml · nonDerivative · entry 1 Kelly Jared · CIK 0002103581 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.820 to $0.856, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 12:00 UTC |
Seizinger Bernd R.Director
|
PurchaseCommon Shares | 60,000 | $0.83 | $49,590.00 |
DisclosureSEC source: 0001493152-26-006548 · ownership.xml · nonDerivative · entry 1 Seizinger Bernd R. · CIK 0001789042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,991 Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 12:00 UTC |
Aromando AndrewChief Business Officer
|
PurchaseCommon Shares | 29,600 | $0.86 | $25,417.52 |
DisclosureSEC source: 0001493152-26-006541 · ownership.xml · nonDerivative · entry 1 Aromando Andrew · CIK 0001976455 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 21:30 UTC |
Seizinger Bernd R.Director
|
PurchaseCommon Shares | 100,000 | $1.04 | $103,770.00 |
DisclosureSEC source: 0001493152-26-002879 · ownership.xml · nonDerivative · entry 1 Seizinger Bernd R. · CIK 0001789042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,991 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0294 to $1.0499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.